Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CARE
CARE logo

CARE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Carter Bankshares Inc (CARE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
22.880
1 Day change
4.28%
52 Week Range
22.910
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Carter Bankshares Inc (CARE) is not a strong buy at this time for a beginner investor with a long-term strategy. While the stock shows bullish technical indicators, the overbought RSI suggests a potential near-term pullback. Additionally, the lack of significant positive catalysts, neutral trading sentiment, and mixed financial performance do not provide a compelling case for immediate investment.

Technical Analysis

The stock exhibits bullish technical indicators with a positive MACD histogram, bullish moving averages (SMA_5 > SMA_20 > SMA_200), and a price above key resistance levels. However, the RSI of 86.134 indicates the stock is overbought, suggesting a potential short-term pullback.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
12

Positive Catalysts

  • Bullish technical indicators such as MACD and moving averages. Revenue growth of 14.91% YoY in the latest quarter.

Neutral/Negative Catalysts

  • RSI indicates overbought conditions. Net income dropped by -3.95% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress. Neutral sentiment in options and trading trends.

Financial Performance

In Q3 2025, revenue increased by 14.91% YoY to $36,763,000, but net income dropped by -3.95% YoY to $5,351,000. EPS remained flat at 0.24 YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast CARE stock price to rise
1 Analyst Rating
Wall Street analysts forecast CARE stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 21.940
sliders
Low
22
Averages
22
High
22
Current: 21.940
sliders
Low
22
Averages
22
High
22
Freedom Capital
Buy
initiated
$23
AI Analysis
2025-12-25
Reason
Freedom Capital
Price Target
$23
AI Analysis
2025-12-25
initiated
Buy
Reason
Freedom Capital initiated coverage of Carter Bankshares with a Buy rating and $23 price target. The firm says Carter offers a "regionally focused growth story" with loan expansion, improving margins, and a stable core deposit base across its Virginia and North Carolina markets. The bank is on a path to higher profitability, the analyst tells investors in a research note.

People Also Watch